LONDON (Alliance News) - The chair of healthcare advisory firm Cello Health PLC said Wednesday it expects its full-year results in line with expectations after a "very good" start to 2019.
Speaking at the annual general meeting, Chair Chris Jones explained the firm had "a very good start to the year" with the first quarter seeing like-for-like net revenue and pretax profit both showing "good" growth.
"We are also confident regarding performance in the second quarter, and expect to report robust headline profit before tax growth for the first half of the year," Jones added.
On a divisional basis, Cello Health had an "excellent" first quarter which is expected to extend into the second quarter. Meanwhile, Cello Signal had a "solid" start to the year.
"The group's balance sheet remains strong, with better than expected cash conversion so far in 2019, continuing the strong cash conversion performance delivered in 2018," Jones explained. "The group continues to assess suitable acquisitive growth opportunities in the US."
Shares in Cello were 1.0% higher at 133.36 pence on Wednesday.
